Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Zogenix to Release Third Quarter 2016 Financial Results and Host Conference Call and Webcast on November 7

Posted on: 31 Oct 16

EMERYVILLE, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that it will report its financial results for the third quarter ended September 30, 2016 after the market close, and will host a corporate update conference call and webcast on Monday, November 7, at 4:30 PM Eastern Time.

Monday, November 7 @ 4:30 PM Eastern Time/1:30 PM Pacific Time
Toll Free:877-675-4749
Conference ID:1385531
Replays, available through November 21: 
Replay PIN:1385531

About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit


Last updated on: 31/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.